» Articles » PMID: 31139151

The Effect of Wnt Pathway Modulators on Human IPSC-Derived Pancreatic Beta Cell Maturation

Overview
Specialty Endocrinology
Date 2019 May 30
PMID 31139151
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Current published protocols for targeted differentiation of human stem cells toward pancreatic β-cells fail to deliver sufficiently mature cells with functional properties comparable to human islet β-cells. We aimed to assess whether Wnt-modulation could promote the final protocol stages of β-cell maturation, building our hypothesis on our previous findings of Wnt activation in immature hiPSC-derived stage 7 (S7) cells compared to adult human islets and with recent data reporting a link between Wnt/PCP and β-cell maturation. In this study, we stimulated canonical and non-canonical Wnt signaling in hiPSC-derived S7 cells using syntetic proteins including WNT3A, WNT4, WNT5A and WNT5B, and we inhibited endogenous Wnt signaling with the Tankyrase inhibitor G007-LK (TKi). Whereas neither canonical nor non-canonical Wnt stimulation alone was able to mature hiPSC-derived S7 cells, WNT-inhibition with TKi increased the fraction of monohormonal cells and global proteomics of TKi-treated S7 cells showed a proteomic signature more similar to adult human islets, suggesting that inhibition of endogenous Wnt contributes toward final β-cell maturation.

Citing Articles

Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors.

Poon F, Sambathkumar R, Korytnikov R, Aghazadeh Y, Oakie A, Misra P Nat Commun. 2024; 15(1):8754.

PMID: 39384787 PMC: 11464881. DOI: 10.1038/s41467-024-53068-w.


Cell identity dynamics and insight into insulin secretagogues when employing stem cell-derived islets for disease modeling.

Wang C, Abadpour S, Aizenshtadt A, Dalmao-Fernandez A, Hoyem M, Wilhelmsen I Front Bioeng Biotechnol. 2024; 12:1392575.

PMID: 38933536 PMC: 11199790. DOI: 10.3389/fbioe.2024.1392575.


Heterozygous missense variant in GLI2 impairs human endocrine pancreas development.

Mueller L, Isaacson A, Wilson H, Salowka A, Tay I, Gong M Nat Commun. 2024; 15(1):2483.

PMID: 38509065 PMC: 10954617. DOI: 10.1038/s41467-024-46740-8.


Targeted Gene Silencing by Using GapmeRs in Differentiating Human-Induced Pluripotent Stem Cells (hiPSC) Toward Pancreatic Progenitors.

Unger L, Ghila L, Chera S Methods Mol Biol. 2023; 2736:23-38.

PMID: 37615889 DOI: 10.1007/7651_2023_498.


Inferring regulators of cell identity in the human adult pancreas.

Vanheer L, Fantuzzi F, To S, Schiavo A, Van Haele M, Ostyn T NAR Genom Bioinform. 2023; 5(3):lqad068.

PMID: 37435358 PMC: 10331937. DOI: 10.1093/nargab/lqad068.


References
1.
Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan P, Yang Y . Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol. 2003; 162(5):899-908. PMC: 2172823. DOI: 10.1083/jcb.200303158. View

2.
Veeman M, Axelrod J, Moon R . A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell. 2003; 5(3):367-77. DOI: 10.1016/s1534-5807(03)00266-1. View

3.
Nelson W, Nusse R . Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004; 303(5663):1483-7. PMC: 3372896. DOI: 10.1126/science.1094291. View

4.
Logan C, Nusse R . The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20:781-810. DOI: 10.1146/annurev.cellbio.20.010403.113126. View

5.
Mikels A, Nusse R . Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006; 4(4):e115. PMC: 1420652. DOI: 10.1371/journal.pbio.0040115. View